Louisiana Medicaid access for treatment and care for hepatitis C virus (LA-MATCH) project: A cross-sectional study protocol.

<h4>Introduction</h4>This article presents the Louisiana Hepatitis C Elimination Program's evaluation protocol underway at the Louisiana State University Health Sciences Center-New Orleans. With the availability of direct-acting antiviral (DAA) agents, the elimination of Hepatitis C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hasheemah Afaneh, Susanne Straif-Bourgeois, Evrim Oral, Ashley Wennerstrom, Olivia Sugarman, William T Robinson, Angel Whittington, Edward Trapido
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/edd5ea92bcdd449698e18b61751f4f6b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:edd5ea92bcdd449698e18b61751f4f6b
record_format dspace
spelling oai:doaj.org-article:edd5ea92bcdd449698e18b61751f4f6b2021-12-02T20:17:20ZLouisiana Medicaid access for treatment and care for hepatitis C virus (LA-MATCH) project: A cross-sectional study protocol.1932-620310.1371/journal.pone.0257437https://doaj.org/article/edd5ea92bcdd449698e18b61751f4f6b2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0257437https://doaj.org/toc/1932-6203<h4>Introduction</h4>This article presents the Louisiana Hepatitis C Elimination Program's evaluation protocol underway at the Louisiana State University Health Sciences Center-New Orleans. With the availability of direct-acting antiviral (DAA) agents, the elimination of Hepatitis C (HCV) has become a possibility. The HCV Elimination Program was initiated by the Louisiana Department of Health (LDH) Office of Public Health (OPH), LDH Bureau of Health Services Financing (Medicaid), and the Louisiana Department of Public Safety and Corrections (DPSC) to provide HCV treatment through an innovative pricing arrangement with Asegua Therapeutics, whereby a fixed cost is set for a supply of treatment over five years.<h4>Materials and methods</h4>A cross-sectional study design will be used. Data will be gathered from two sources: 1) an online survey administered via REDCap to a sample of Medicaid members who are receiving HCV treatment, and 2) a de-identified data set that includes both Medicaid claims data and OPH surveillance data procured via a Data Use Agreement between LSUHSC-NO and Louisiana Medicaid.<h4>Discussion</h4>The evaluation will contribute to an understanding of the scope and reach of this innovative treatment model, and as a result, an understanding of areas for improvement. Further, this evaluation may provide insight for other states considering similar contracting mechanisms and programs.Hasheemah AfanehSusanne Straif-BourgeoisEvrim OralAshley WennerstromOlivia SugarmanWilliam T RobinsonAngel WhittingtonEdward TrapidoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 10, p e0257437 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hasheemah Afaneh
Susanne Straif-Bourgeois
Evrim Oral
Ashley Wennerstrom
Olivia Sugarman
William T Robinson
Angel Whittington
Edward Trapido
Louisiana Medicaid access for treatment and care for hepatitis C virus (LA-MATCH) project: A cross-sectional study protocol.
description <h4>Introduction</h4>This article presents the Louisiana Hepatitis C Elimination Program's evaluation protocol underway at the Louisiana State University Health Sciences Center-New Orleans. With the availability of direct-acting antiviral (DAA) agents, the elimination of Hepatitis C (HCV) has become a possibility. The HCV Elimination Program was initiated by the Louisiana Department of Health (LDH) Office of Public Health (OPH), LDH Bureau of Health Services Financing (Medicaid), and the Louisiana Department of Public Safety and Corrections (DPSC) to provide HCV treatment through an innovative pricing arrangement with Asegua Therapeutics, whereby a fixed cost is set for a supply of treatment over five years.<h4>Materials and methods</h4>A cross-sectional study design will be used. Data will be gathered from two sources: 1) an online survey administered via REDCap to a sample of Medicaid members who are receiving HCV treatment, and 2) a de-identified data set that includes both Medicaid claims data and OPH surveillance data procured via a Data Use Agreement between LSUHSC-NO and Louisiana Medicaid.<h4>Discussion</h4>The evaluation will contribute to an understanding of the scope and reach of this innovative treatment model, and as a result, an understanding of areas for improvement. Further, this evaluation may provide insight for other states considering similar contracting mechanisms and programs.
format article
author Hasheemah Afaneh
Susanne Straif-Bourgeois
Evrim Oral
Ashley Wennerstrom
Olivia Sugarman
William T Robinson
Angel Whittington
Edward Trapido
author_facet Hasheemah Afaneh
Susanne Straif-Bourgeois
Evrim Oral
Ashley Wennerstrom
Olivia Sugarman
William T Robinson
Angel Whittington
Edward Trapido
author_sort Hasheemah Afaneh
title Louisiana Medicaid access for treatment and care for hepatitis C virus (LA-MATCH) project: A cross-sectional study protocol.
title_short Louisiana Medicaid access for treatment and care for hepatitis C virus (LA-MATCH) project: A cross-sectional study protocol.
title_full Louisiana Medicaid access for treatment and care for hepatitis C virus (LA-MATCH) project: A cross-sectional study protocol.
title_fullStr Louisiana Medicaid access for treatment and care for hepatitis C virus (LA-MATCH) project: A cross-sectional study protocol.
title_full_unstemmed Louisiana Medicaid access for treatment and care for hepatitis C virus (LA-MATCH) project: A cross-sectional study protocol.
title_sort louisiana medicaid access for treatment and care for hepatitis c virus (la-match) project: a cross-sectional study protocol.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/edd5ea92bcdd449698e18b61751f4f6b
work_keys_str_mv AT hasheemahafaneh louisianamedicaidaccessfortreatmentandcareforhepatitiscviruslamatchprojectacrosssectionalstudyprotocol
AT susannestraifbourgeois louisianamedicaidaccessfortreatmentandcareforhepatitiscviruslamatchprojectacrosssectionalstudyprotocol
AT evrimoral louisianamedicaidaccessfortreatmentandcareforhepatitiscviruslamatchprojectacrosssectionalstudyprotocol
AT ashleywennerstrom louisianamedicaidaccessfortreatmentandcareforhepatitiscviruslamatchprojectacrosssectionalstudyprotocol
AT oliviasugarman louisianamedicaidaccessfortreatmentandcareforhepatitiscviruslamatchprojectacrosssectionalstudyprotocol
AT williamtrobinson louisianamedicaidaccessfortreatmentandcareforhepatitiscviruslamatchprojectacrosssectionalstudyprotocol
AT angelwhittington louisianamedicaidaccessfortreatmentandcareforhepatitiscviruslamatchprojectacrosssectionalstudyprotocol
AT edwardtrapido louisianamedicaidaccessfortreatmentandcareforhepatitiscviruslamatchprojectacrosssectionalstudyprotocol
_version_ 1718374437850447872